Amneal has said it will use its leadership and financial position to fully realize the potential of Interpharm’s product line, ensure approval of its development pipeline and leverage the manufacturing capabilities.
Chintu Patel, CEO of Amneal, said: “Utilizing Amneal’s financial strength, superb quality management, R&D and manufacturing expertise with Interpharm’s outstanding facilities, leading market share and high value pipeline creates tremendous opportunities for rapid growth and exceptional customer satisfaction.”